BioInformant

Your Global Leader in Stem Cell Market Research

MENUMENU
  • Blog
    • Interviews
  • News
  • Stem Cells
    • iPS Cells
    • MSCs
    • HSCs
    • Adipose SCs
    • Neural Stem Cells
  • Exosomes
  • CAR-T
  • Cord Blood
  • Shop
    • Products
    • Submit PR
    • Advertise
  • About
    • Testimonials
    • Story
    • Guarantee
    • Contact
  • Home
  • Blog
    • Stem Cells
      • HSCs
      • iPS Cells
      • MSCs
      • Neural Stem Cells
      • Adipose SCs
    • Exosomes
    • Cell Therapy
      • CAR-T
    • Cord Blood
    • Stem Cell News
    • Interviews
  • COVID-19
  • Shop
  • Submit PR
  • Company
    • Advertise
    • Testimonials
    • Story
    • Job Posts
    • Guarantee
    • Privacy Policy
    • Contact
Home » Stem Cells » HSCs

Hematopoietic Stem Cells (HSCs)

What Stem Cell Clinics Do You Trust?

June 22, 2022 By Cade Hildreth (CEO) 11 Comments

Feature | What Stem Cell Clinics Do You Trust?

This article explores leading stem cell centers within the U.S. and worldwide. Read on to learn about this emerging area of medicine. [Read more…]

Filed Under: Adipose SCs, HSCs, MSCs, Stem Cells Tagged With: Celltex, GIOSTAR, Okyanos, Regenexx, Stem Cell Institute

Cord Blood Industry Consolidation Escalates in 2022

June 11, 2022 By Cade Hildreth (CEO) 2 Comments

cord blood industry

The global cord blood industry experienced strong growth from the early 1990’s through the late 2000’s, during which time more than 450 cord blood banking companies emerged worldwide. Approximately half of those companies owned their own labs, while the others were marketing entities or sub-contractors of storage space.

Starting about ten years ago, the market suddenly changed course. It entered a period of aggressive consolidation, cutting the global number of cord blood banks by approximately half.

Over the past decade, the cord blood industry has witnessed substantial consolidation, particularly within the United States, Europe, Asia, and Latin America. [Read more…]

Filed Under: Cord Blood, HSCs Tagged With: cord blood, merger, news, trends

Cord Blood Market Segmentation in 2022

June 2, 2022 By Cade Hildreth (CEO) Leave a Comment

Cord Blood Market Segmentation

Cord blood market segmentation is one of the most important (and least appreciated) parts of analyzing the cord blood banking industry. As the first and only market research firm to track the stem cell industry, BioInformant has collected over 16 years of historical information on the cord blood industry from 2006 to present. This provides a powerful record if past industry dynamics, as well as a robust platform for making future projections. [Read more…]

Filed Under: HSCs, MSCs, Stem Cells Tagged With: cell therapy, cord blood, HSCT, market segmentation

Who Is CryoHoldco? Latin America’s Largest Cord Blood Bank

April 16, 2022 By Cade Hildreth (CEO) Leave a Comment

CryoHoldco is a stem cell bank holding company that is the market leader in Latin America and one of the top 10 largest cord blood banks in the world. CryoHoldco is now seven times larger than any other stem cell bank in Latin America with over 275,000 stem cell units in storage.

[Read more…]

Filed Under: Cord Blood, HSCs, MSCs, Stem Cells Tagged With: cord blood, CryoHoldco, news

Pivotal Trends Impacting the Global Cord Blood Industry in 2022

March 7, 2022 By Cade Hildreth (CEO) Leave a Comment

cord blood trends

The cord blood industry came into existence in the early 1990’s with the formation of several cord blood banks in the U.S. and worldwide. It has also been almost 40 years since it was first proposed that stem and progenitor cells were present in human cord blood. [Read more…]

Filed Under: Cord Blood, HSCs Tagged With: cord blood, news

  • 1
  • 2
  • 3
  • …
  • 31
  • Next Page »

Nanocellect

Marathon Products

Kimera Society

Let’s Get Social

  • Facebook
  • Twitter
  • LinkedIn
  • Pinterest
  • Instagram

Cart

Top Rated Products

  • Job Posting on BioInformant <Job Posting on BioInformant.com - Your Perfect Hire Is In Our Audience $297
  • U.S. Cord Blood Banking Survey <Cord Blood Banking Survey of U.S. Parents [2017] $197
  • Exosome Companies 2020 <Global Database of Exosome Companies $149 $97

Featured Posts

iPSC derived cell therapeutics

The Pipeline for iPSC-Derived Cell Therapeutics in 2022

Stem cell companies

List of Stem Cell Companies Worldwide (2022)

Feature | Exosome Companies | Exosome Companies | Tiny Exosomes, Enormous Potential

List of Exosome Companies: Tiny Packages, Enormous Potential

My Tweets

BioInformant's World-Class Clients

  • Submit Press Release
  • Advertise
  • Privacy and Terms

Copyright © 2022 · BIOINFORMANT, Your Global Leader in Stem Cell Market Research

| Email: [email protected] | Phone: 703-859-7617 |

800 Corporate Drive, Suite 301, Stafford, VA 22554, United States

Disclaimer: All statements made on this website are NOT expressed as medical claims or advice. They are not intended to diagnose, treat, cure or prevent any disease or condition. If you have a health condition or concern, consult your physician or health care provider.